Gene · 8038
Papers1,979
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 1,979
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The involvement of MALAT1-ALKBH5 signaling axis into proliferation and metastasis of human papillomavirus-positive cervical cancer. | Cancer Biol Ther | 2023 | 37639643 | PubTator, text mining | PubMed |
| Single-cell RNA-seq analysis reveals that immune cells induce human nucleus pulposus ossification and degeneration. | Front Immunol | 2023 | 37638033 | PubTator, text mining | PubMed |
| Genetic and Epigenetic Features of Uveal Melanoma-An Overview and Clinical Implications. | Int J Mol Sci | 2023 | 37628989 | PubTator, text mining | PubMed |
| Skin Gene Expression Profiles in Systemic Sclerosis: From Clinical Stratification to Precision Medicine. | Int J Mol Sci | 2023 | 37628728 | PubTator, text mining | PubMed |
| An Improved Protocol for Targeted Differentiation of Primed Human Induced Pluripotent Stem Cells into HLA-G-Expressing Trophoblasts to Enable the Modeling of Placenta-Related Disorders. | Cells | 2023 | 37626882 | PubTator, text mining | PubMed |
| RNA modification: mechanisms and therapeutic targets. | Mol Biomed | 2023 | 37612540 | PubTator, text mining | PubMed |
| Characterization of m6A modifiers and RNA modifications in uterine fibroids. | bioRxiv | 2023 | 37609293 | PubTator, text mining | PubMed |
| Pancancer network analysis reveals key master regulators for cancer invasiveness. | J Transl Med | 2023 | 37599366 | PubTator, text mining | PubMed |
| Aberrant activation of five embryonic stem cell-specific genes robustly predicts a high risk of relapse in breast cancers. | BMC Genomics | 2023 | 37592220 | PubTator, text mining | PubMed |
| ADAM8 is expressed widely in breast cancer and predicts poor outcome in hormone receptor positive, HER-2 negative patients. | Cancer Cell Int | 2023 | 37568162 | PubTator, text mining | PubMed |
| Extravillous trophoblast cell lineage development is associated with active remodeling of the chromatin landscape. | Nat Commun | 2023 | 37563143 | PubTator, text mining | PubMed |
| Correlation investigation between a single nucleotide polymorphism in ADAMTS14 (rs4747096) and osteoarthritis: a meta-analysis. | J Orthop Surg Res | 2023 | 37550675 | PubTator, text mining | PubMed |
| Platelet-rich plasma in the pathologic processes of tendinopathy: a review of basic science studies. | Front Bioeng Biotechnol | 2023 | 37545895 | PubTator, text mining | PubMed |
| Biomarkers in Duchenne Muscular Dystrophy: Current Status and Future Directions. | J Neuromuscul Dis | 2023 | 37545256 | PubTator, text mining | PubMed |
| Total RNA sequencing reveals gene expression and microbial alterations shared by oral pre-malignant lesions and cancer. | Hum Genomics | 2023 | 37542347 | PubTator, text mining | PubMed |
| Proregenerative extracellular matrix hydrogel mitigates pathological alterations of pelvic skeletal muscles after birth injury. | Sci Transl Med | 2023 | 37531414 | PubTator, text mining | PubMed |
| The Latest Developments in Using Proteomic Biomarkers from Urine and Serum for Non-Invasive Disease Diagnosis and Prognosis. | Biomark Insights | 2023 | 37528936 | PubTator, text mining | PubMed |
| Clinical, molecular, and immune correlates of the Immunotherapy Response Score in patients with advanced urothelial carcinoma under atezolizumab monotherapy: analysis of the phase II IMvigor210 trial. | ESMO Open | 2023 | 37516059 | PubTator, text mining | PubMed |
Peonidin-3-O-glucoside and Resveratrol Increase the Viability of Cultured Human hFOB Osteoblasts and Alter the Expression of Genes Associated with Apoptosis, Osteoblast Differentiation and Osteoclastogenesis. | Nutrients | 2023 | 37513651 | PubTator, text mining | PubMed |
| Derivation of Human Extraembryonic Mesoderm-like Cells from Primitive Endoderm. | Int J Mol Sci | 2023 | 37511125 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8038/papers?page=9